Latest California Healthline Stories
Genetics Studies Have a Diversity Problem That Researchers Struggle To Fix
Researchers in Charleston, South Carolina, are trying to build a DNA database of 100,000 people to better understand how genetics affects health risks. But they’re struggling to recruit enough Black participants.
KFF Health News' 'What the Health?': A Very Good Night for Abortion Rights Backers
Abortion rights backers won major victories in at least five states in the 2023 off-year elections Nov. 7, proving the staying power of abortion as a political issue in the wake of the Supreme Court’s 2022 decision overturning Roe v. Wade. Meanwhile, the National Institutes of Health finally has a new director, after Democrats temporarily blocked President Joe Biden’s nominee over a mostly unrelated fight about prescription drug prices. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Julie Appleby, who reported and wrote the latest “Bill of the Month” feature.
KFF Health News' 'What the Health?': The New Speaker’s (Limited) Record on Health
The House finally has a new speaker: Mike Johnson (R-La). He’s a relative newcomer who’s been a lower-level member of the House GOP leadership. And while he’s an outspoken opponent of abortion and same-sex marriage, his record on other health issues is scant. Meanwhile, the National Institutes of Health appears on track to be getting a new director, and Georgia’s Medicaid work requirement experiment is off to a very slow start. Alice Miranda Ollstein of Politico and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Michael Cannon, director of health policy studies at the Cato Institute, a libertarian think tank.
Biden Pick to Lead NIH Finally Has Her Day, but Still Gets Caught Up in Drug Price Debate
Monica Bertagnolli, the president’s choice to head the National Institutes of Health, appeared before a Senate committee this week. Her confirmation has been held up by Sen. Bernie Sanders (I-Vt.), who has demanded President Joe Biden work more aggressively to lower prescription drug prices.
The NIH Ices a Research Project. Is It Self-Censorship?
The National Institutes of Health appeared to be digging into health misinformation. But then the federal agency stepped back. It can’t quite explain why, sometimes even offering contradictory explanations.
KFF Health News' 'What the Health?': Congress Is Out. The Presidential Campaign Is In.
Congress is in recess until after Labor Day, and lawmakers won’t have much time when they return to get the government funded before the next fiscal year. Meanwhile, the Republican campaign for president has begun in earnest, and while repealing the Affordable Care Act is no longer the top promise, some candidates have lively ideas about what to do with federal health programs. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Phil Galewitz, who reported the latest KFF Health News-NPR “Bill of the Month,” about how a bill that should never have been sent created headaches for one patient.
KFF Health News' 'What the Health?': Let’s Talk About the Weather
2023 will likely be remembered as the summer Arizona sizzled, Vermont got swamped, and nearly the entire Eastern Seaboard, along with huge swaths of the Midwest, choked on wildfire smoke from Canada. Still, none of that has been enough to prompt policymakers in Washington to act on climate issues. Meanwhile, at a public court hearing, […]
Watch: Beyond the Script of ‘The G Word’ and How Government Responds to Disease (Or Not)
KHN Editor-in-Chief Elisabeth Rosenthal joins comedian Adam Conover to discuss his new Netflix series, “The G Word,” which examines the federal government’s role in Americans’ lives, and how it plays out in the covid era.
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
KHN’s ‘What the Health?’: Funding for the Next Pandemic
In his proposed budget, President Joe Biden called for a boost in health spending that includes billions of dollars to prepare for a future pandemic. But that doesn’t include money he says is needed immediately for testing and treating covid-19. Also this week, federal regulators authorized a second booster shot for people 50 and older yet gave little guidance to consumers about who needs the shot and when. Amy Goldstein of The Washington Post, Jennifer Haberkorn of the Los Angeles Times, and Rachana Pradhan of KHN join KHN’s Mary Agnes Carey to discuss these issues and more. Plus, Julie Rovner interviews KHN’s Julie Appleby, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a very expensive air ambulance ride.